Flow cytometry analysis of human fetal osteoblast fate processes on spark plasma sintered hydroxyapatite-titanium biocomposites

Journal of Biomedical Materials Research - Part A

Volumn 101, Issue 10, 2013, Pages 2925-2938

  Kumar, Alok ^a   Webster, Thomas J ^b   Biswas, Krishanu ^a   Basu, Bikramjit ^a,c  

^a INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

^b Northeastern University   (United States)

^c INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

apoptosis; cell cycle; flow cytometry; HA Ti; proliferation

Indexed keywords

CELL CYCLE; CYTOCOMPATIBILITY; FLOW CYTOMETRY ANALYSIS; HA-TI; HUMAN OSTEOBLAST-LIKE CELLS; PROLIFERATION; PROLIFERATION INDEX; TISSUE CULTURE POLYSTYRENES;

CELL DEATH; CELL PROLIFERATION; COMPOSITE MATERIALS; FLOW CYTOMETRY; HYDROXYAPATITE; SPARK PLASMA SINTERING; TISSUE CULTURE; TITANIUM; TOUGHNESS;

BIOMECHANICS;

HYDROXYAPATITE; POLYSTYRENE; TITANIUM;

APOPTOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL ADHESION; CELL CYCLE PROGRESSION; CELL DEATH; CELL DIVISION; CELL FATE; CELL MEMBRANE; CELL METABOLISM; CELL PROLIFERATION; CELL STRUCTURE; CELL SUSPENSION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; OSTEOBLAST; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

APOPTOSIS; CELL CYCLE; FLOW CYTOMETRY; HA-TI; PROLIFERATION;

APOPTOSIS; BIOCOMPATIBLE MATERIALS; CELL CYCLE; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; DURAPATITE; FETUS; FLOW CYTOMETRY; HUMANS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; PLASMA GASES; SURFACE PROPERTIES; TITANIUM;

EID: 84883237425     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34603     Document Type: Article

References (70)

1. Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials Science: An Introduction to Materials in Medicine, 2nd ed. California, USA: Elsevier Academic Press; 2004.
2. Chen T-M, Yao C-H, Wang H-J, Chou G-H, Lee T-W, Lin F-H,. Evalution of a novel malleable, biodegradable osteoconductive composite in a rabbit cranial defect model. Mater Chem Phys 1998; 55: 44-50.
3. Carlson ER, Marx RE, Buck BE, Gables C,. The potential for HIV transmission through allogeneic bone. Oral Surg Oral Med Oral Pathol 1995; 80: 17-23.
4. Barrere F, Blitterswijk CAv, Groot Kd,. Bone regeneration: Molecular and cellular interactions with calcium phosphate cramics. Int J Nanomed 2006; 1: 317-332.
5. Schmitz JP, Hollinger JO,. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986; 205: 299-308.
6. Hench LL,. Bioceramics: Concept to clinics. J Am Ceram Soc 1991; 74: 1487-1570.
7. Hench LL, Paschall HA,. Direct bonding of bioactive glass ceramics to bone and muscle. J Biomed Mater Res 1973; 4: 25-42.
8. Osborn JF, Newesely H,. The material science of calcium phosphate ceramics. Biomaterials 1980; 1: 108-111.
9. LeGeros RZ,. Properties of osteoconductive biomaterials: Calcium phosphate. Clin Orthop Relat Res 2002; 395: 81-98.
10. R, A-W glass-ceramic, and hydroxyapatite. J Biomed Mater Res 2000; 51: 37-46.
11. Urist MR, Silverman BF, Buring K, Dubuc FI, Rosenberg J,. The bone induction principle. Clin Orthop 1967; 53: 243-283.
12. Zhou H, Lee J,. Nanoscale hydroxyapatite particles for bone tissue engineering. Acta Biomater 2011; 7: 2769-2781.
13. Poinern GE, Brundavanam RK, Mondinos N, Jiang ZT,. Synthesis and characterization of nanohydroxyapatite using an ultrasound assisted method. Ultrason Sonochem 2009; 16: 469-474.
14. Legeros RZ,. Biodegradation and bioresorption of calcium phosphate ceramics. Clin Mater 1993; 14: 65-88.
15. Bohner M,. Calcium othrophsphates in medicine: From ceramics to calcium phosphate cements. Injury 2000; 31: D37-D47.
16. Gu YW, Khora KA, Cheang P,. Bone-like apatite layer formation on hydroxyapatite prepared by spark plasma sintering (SPS). Biomaterials 2004; 25: 4127-4134.
17. Hench LL,. Bioceramics. J Am Ceram Soc 1998; 81: 1705-1728.
18. Hutmacher DW, Schantz JT, Lam CXF, Tan KC, Lim TC,. State of the art and future directions of scaffold based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 2007; 1: 245-260.
19. Habraken W, Wolke JGC, Jansen JA,. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007; 59: 234-248.
20. Nakahira A, Eguchi K,. Evalution of microstructure and some properties of hydroxyapatite/Ti composites. J Ceram Process Res 2001; 2: 108-112.
21. Jarcho M, Bolen CH, Thomas MB, Bobick J, Kay JF, Doremus H,. Hydroxyapatite synthesis and characterization in dense polycrystalline form. J Mater Sci 1976; 11: 2027-2035.
22. Noort Rv,. Titanium: The implant material of today. J Mater Sci 1987; 22: 3801-3811.
23. Nath S, Tripathi R, Basu B,. Understanding phase stability, microstructure development and biocompatibility in calcium phosphate-titania composites, synthesized from hydroxyapatite and titanium powder mix. Mater Sci Eng C 2009; 29: 97-107.
24. Yang Y, Kim K-H, Agrawal CM, Ong JL,. Interaction of hydroxyapatite- titanium at elevated temperature in vacuum environment. Biomaterials 2004; 25: 2927-2932.
25. Chu C, Lin P, Dong Y, Xue X, Zhu J, Yin Z,. Fabrication and characterization of hydroxyapatite reinforced with 20 vol%Ti particles for use as hard tissue replacement. J Mater Sci: Mater Med 2002; 13: 985-992.
26. Fahami A, Ebrahimi-Kahrizsangi R, Nasiri-Tabrizi B,. Mechanochemical synthesis of hydroxyapatite/titanium nanocomposite. Solid State Sci 2011; 13: 135-141.
27. Ning CQ, Zhou Y,. In vitro bioactivity of a biocomposite fabricated from HA and Ti powder by powder metallurgy method. Biomaterials 2002; 23: 2909-2915.
28. Kumar A, Dhara S, Biswas K, Basu B,. In vitro bioactivity and cytocompatibility properties of spark plasma sintered HA-Ti composites. J Biomed Mater Res Part B: Appl Biomater 2013; 101B: 223-236.
29. Kumar A, Mallik AK, Acikbas NC, Yaygingol M, Kara F, Mandal H, Basu D, Biswas K, Basu B,. Cytocompatibility property evaluation of gas pressure sintered SiAlON-SiC composites with L929 fibroblast cells and Saos-2 osteoblast-like cells. Mater Sci Eng C 2012; 32: 464-469.
30. Alliot-Licht B, Gregoire M, Orly I, Menanteau J,. Cellular activity of osteoblasts in the presence of hydroxyapatite: An in vitro experiment. Biomaterials 1991; 12: 752-756.
31. Wang Y-Y, Zheng X-X,. A flow cytometry-based assay for quantitative analysis of cellular proliferation and cytotoxicity in vitro. J Immunol Methods 2002; 268: 179-188.
32. Palsson BO, Bhatia SN,. Tissue Engineering. New Delhi, India: Pearson Education India; 2009. 432 pp.
33. Postiglione L, Domenico GD, Ramaglia L, Montagnani S, Salzano S, Meglio FD, Sbordone L, Vitale M, Rossi G,. Behavior of SaOS-2 cells cultured on different titanium surfaces. J Dental Res 2003; 82: 692-696.
34. Kane KL, Ashton FA, Schmitz JL, Folds JD,. Determination of natural killer cell function by flow cytometry. Clin Diagn Lab Immunol 1996; 3: 295-300.
35. Gutensohn K, Kuehnl P,. The role of flow cytometry in improving biocompatibility in transfusion medicine. Transfus Sci 1998; 19: 17-25.
36. Aubry J-P, Blaecke A, Lecoanet-Henchoz S, Jeannin P, Herbault N, Caron G, Moine V, Bonnefoy J-Y,. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry 1999; 37: 197-204.
37. Span LFR, Pennings AHM, Vierwinden G, Boezeman JBM, Raymakers RAP, Witte Td,. The dynamic process of apoptosis analyzed by flow cytometry using Annexin-V/Propidium iodide and a modified in situ end labeling technique. Cytometry 2002; 47: 24-31.
38. Lopes MA, Knowless JC, Kuru L, Santos JD, Monteiro FJ, Olsen I,. Flow cytometry for assessing biocompatibility. J Biomed Mater Res 1998; 41: 649-656.
39. Tagai H, Aoki H,. Preparation of Synthetic Hydroxyapatite and Sintering of Apatite Ceramics. New York, USA: John Wiley & Sons; 1980.
40. Wu W, Giese RFJ, Oss CJv,. Evaluation of the Lifshitz-van der Waals/acid-base approach to determine surface tension components. Langmuir 1995; 11: 379-382.
41. Mosmann T,. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J Immunol Methods 1983; 65: 55-63.
42. Yuksel N, Kanik AE, Baykara T,. Comparision of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int J Pharm 2000; 209: 57-67.
43. Ball MD, McCartney DG,. The measurement of atomic number and composition in an SEM using backscattered detectors. J Microsc 1981; 124: 57-68.
44. Joy DC,. Beam interactions, contrast and resolution in the SEM. J Microsc 1984; 136: 241-258.
45. Op den Kamp JAF,. Lipid asymmetry in membranes. Ann Rev Biochem 1979; 48 (1): 47-71.
46. Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C,. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184 (1): 39-51.
47. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM,. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macophages. J Immunol 1992; 148: 2207-2216.
48. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM,. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 1990; 265: 4923-49228.
49. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, Oers MHJv,. Annexin V for flow cytometric detection of phsphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415-1420.
50. Zachowski A, Herrmann A, Paraf A, Devaux PF,. Phospholipid outside-inside translocation in lymphocte plasma membrane is a protein-mediated phenomena. Biochim Biophys Acta 1987; 897: 197-200.
51. Pozarowski P, Grabarek J, Darzynkiewicz Z,. Flow Cytometry of Apoptosis. Current protocol in cytometry 2003; supplement 25, 7.19.1-7.19.33.
52. Butterworth BE, Slaga TJ, Farland W,. Chemically induced cell proliferation implication for risk assessment. New York, NY: Wiley-Liss; 1991.
53. Freshney RI,. Culture of animal cells: A manual of basic technique, 5th ed., New Jersey, USA, John Wiley & Sons, 2005.
54. Weston SA, Parish CR,. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods 1990; 133: 87-97.
55. Lyons AB, Parish CR,. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994; 171: 131-137.
56. Hartwell LH, Weinert TA,. Checkpoints: Controls that ensure the order of cell cycle events. Science 1989; 246: 629-634.
57. Cohen JJ,. Programmed cell death in the immune system. Adv Immunol 1991; 50: 55-85.
58. Arends MJ, Wyllie AH,. Apoptosis: Mechanisms and roles in pathalogy. Int Rev Exp Pathol 1991; 32: 223-254.
59. Raff MC,. Social controls on cell survival and cell death. Nature 1992; 356: 397-400.
60. Ormerod MG,. Investigating the relatioship between the cell cycle and apoptosis using flow cytometry. J Immunol Methods 2002; 265: 73-80.
61. Fransen JH, Vlag Jvd, Ruben J, Adema GJ, Berden JH, Hilbrands LB,. The role of dendritic cells in the pathojenesis of systemic lupus erythematosus. Arthritis Res Ther 2010; 12: 207-215.
62. Braber ETd, Ruijter JEd, Smits HTJ, Ginsel LA, Recum AFv, Jansen JA,. Quantitative analysis of cell proliferation and orientation on substrata with uniform parallel surface micro-grooves. Biomaterials 1996; 17: 1093-1099.
63. Linez-Bataillon P, Monchau F, Bigerelle M, Hildebrand HF,. In vitro MC3T3 osteoblast adhesion with respect to surface roughness of Ti6Al4V substrates. Biomol Eng 2002; 19: 133-141.
64. Deligianni DD, Katsala N, Ladas S, Sotiropoulou D, Amedee J, Missirlis YF,. Effect of suface roughness of the titanium alloy Ti-6Al-4V on human bone marrow cell response and on protein adsorption. Biomaterials 2001; 22: 1241-1251.
65. Anselme K, Linez P, Bigerelle M, Maguer DL, Maguer AL, Hardouin P, Hildebrand HF, Iost A, Leroy JM,. The relative influence of the topography and chemistry of TiAl6V4 surfaces on osteoblastic cell behaviour. Biomaterials 2000; 21: 1567-1577.
66. Huang H-H, Ho c-T, Lee T-H, Lee T-L, Liao K-K, Chen F-L,. Effect of surface roughness of ground titanium on initial cell adhesion. Biomol Eng 2004; 21: 93-97.
67. Zayzafoom M,. Calcium/calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem 2006; 97: 56-70.
68. Ahlstrom M, Pekkinen M, Riehle U, Lamberg-Allardt C,. Extracellular calcium regulates parathyroid hormone-related peptide expression in osteoblasts and osteoblast progenitor cells. Bone 2008; 42: 483-490.
69. Dvorak MM, Siddiqua A, Ward DT, Carter DH, Dallas SL, Nemeth EF, Riccardi D,. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci USA 2004; 101: 5140-5145.
70. Gabusi E, Manferdini C, Grassi F, Piacentini A, Cattini L, Filardo G, Lambertini E, Piva R, Zini N, Facchini A, Gina L. Extracellular calcium chronically induced human osteoblasts effects: Specific modulation of osteocalcin and collagen type XV. J Cellular Physiol 2012; 227: 3151-3161.